Replies to post #221802 on Biotech Values

[DewDiligence]

ORTX—(-13%/PM)—25% layoff—new business direction:

https://finance.yahoo.com/news/orchard-therapeutics-unveils-strategic-plan-110010505.html

[DewDiligence]

KYKOY acquires ORTX @$16/ADS cash +CVR—a 97% premium to yesterday’s close (excluding the CVR):

https://finance.yahoo.com/news/kyowa-kirin-acquire-orchard-therapeutics-073500807.html

The nominal deal value is $387M.